The risk of hematopoietic growth factor therapy in newborn infants.
Zipursky
Alvin
A
D000328:Adult; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000139:chemically induced*; D004921:Erythropoietin / Q000009:adverse effects / Q000276:immunology; D016298:Hematopoietic Cell Growth Factors / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007231:Infant, Newborn; D007518:Isoantibodies / Q000276:immunology; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D012306:Risk; D012449:Safety
D001323:Autoantibodies; D016298:Hematopoietic Cell Growth Factors; D007074:Immunoglobulin G; D007518:Isoantibodies; D004921:Erythropoietin